| Year |
Citation |
Score |
| 2021 |
Grossman YS, Fillinger C, Manganaro A, Voren G, Waldman R, Zou T, Janssen WG, Kenny PJ, Dumitriu D. Structure and function differences in the prelimbic cortex to basolateral amygdala circuit mediate trait vulnerability in a novel model of acute social defeat stress in male mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 34799681 DOI: 10.1038/s41386-021-01229-6 |
0.398 |
|
| 2018 |
Kenny P, Kamenecka T, Voren G, Duncan A, Howe M, Hollander J, Damez-Warno D, Lu Q, Bali P, Burli R, Gurrell I, Mather RJ, Brandon NJ. 11. Orexin-1 Receptor Antagonists as Novel Smoking Cessation Agents Biological Psychiatry. 83: S4-S5. DOI: 10.1016/J.Biopsych.2018.02.028 |
0.46 |
|
| 2017 |
Wall TR, Henderson BJ, Voren G, Wageman CR, Deshpande P, Cohen BN, Grady SR, Marks MJ, Yohannes D, Kenny PJ, Bencherif M, Lester HA. TC299423, a Novel Agonist for Nicotinic Acetylcholine Receptors. Frontiers in Pharmacology. 8: 641. PMID 29033834 DOI: 10.3389/Fphar.2017.00641 |
0.488 |
|
| 2014 |
Muschamp JW, Hollander JA, Thompson JL, Voren G, Hassinger LC, Onvani S, Kamenecka TM, Borgland SL, Kenny PJ, Carlezon WA. Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area. Proceedings of the National Academy of Sciences of the United States of America. 111: E1648-55. PMID 24706819 DOI: 10.1073/Pnas.1315542111 |
0.488 |
|
| 2013 |
Kenny PJ, Voren G, Johnson PM. Dopamine D2 receptors and striatopallidal transmission in addiction and obesity. Current Opinion in Neurobiology. 23: 535-8. PMID 23726225 DOI: 10.1016/J.Conb.2013.04.012 |
0.491 |
|
| Show low-probability matches. |